{"type":"rich","version":"1.0","provider_name":"Transistor","provider_url":"https://transistor.fm","author_name":"Welcome to the Arena from ICR – Conversations with Today's Innovators & Business Leaders","title":"Peter Milner, Founder & CEO, Renexxion Ireland — Efficacious and Safe: How an innovative new drug could revolutionize the treatment of gastrointestinal disorders","html":"","width":"100%","height":180,"duration":1581,"description":"Millions of people around the world suffer from gastrointestinal issues like gastroparesis, reflux, and constipation, but until now, the available treatments haven’t been very effective, and often carry some pretty nasty potential side effects. Today, we're featuring a company hoping to bring those people relief with a drug that's both efficacious and safe. \n\nToday's guest is Peter Milner, the founder and managing member of Renexxion, where he serves as the CEO of its wholly owned operating subsidiary, Renexxion Ireland Limited, a clinical stage biopharma company committed to delivering innovative drugs to patients with gastrointestinal disorders globally. \n\nPeter’s a board-certified cardiologist, a physician-scientist and a serial entrepreneur with a proven track record of building successful biotechnology companies, including CV Therapeutics and Aptivio Biotechnology, and advancing novel therapeutics from discovery to development. \n\nToday, Peter’s going to walk us through Renexxion’s very promising new drug, the treatment gap it aims to redress, and what it will take to get it through clinical trials and into the hands of patients. \n\n\nHighlights:\nFrom Medicine to Serial Entrepreneur (3:00)\nThe Gap in GI Treatment (3:30)\nHow the Drug Works (6:10)\nWhere Others Failed (5:05)\nTrial Results and the Road to Phase 3 (8:20)\nThe Problem with Current Treatments (9:45)\nThe Dr. Falk Partnership (17:10)\nPipeline in a Pill (20:20)\nThe Billion-Dollar Opportunity (21:45)\nWhat's Next for Renexxion (23:50)\n\nLinks:\nPeter Milner LinkedIn\nRenexxion LinkedIn\nRenexxion Website\nICR LinkedIn\nICR Twitter\nICR Website\n\n \nFeedback:\nIf you have questions about the show, or have a topic in mind you'd like discussed in future episodes, email our producer, joe@lowerstreet.co","thumbnail_url":"https://img.transistorcdn.com/VPbFZOgoHk78hrWlplrfMSrQROUNxI8jcZ2Gv-hyKm4/rs:fill:0:0:1/w:400/h:400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9mYmFh/NWFlNGJjY2Y0NGFk/YmM2NWJiMTI4NmVh/OWQ4Yi5wbmc.webp","thumbnail_width":300,"thumbnail_height":300}